Current Drug Targets
Title:Editorial (Thematic Issue: The Predictive Pathology in the Target Therapy Era)
Volume: 18 Issue: 1
Author(s): Renato Franco and Monica Cantile
Affiliation:
Export Options
About this article
Cite this article as:
Franco Renato and Cantile Monica, Editorial (Thematic Issue: The Predictive Pathology in the Target Therapy Era), Current Drug Targets 2017; 18 (1) . https://dx.doi.org/10.2174/138945011801161202203221
DOI https://dx.doi.org/10.2174/138945011801161202203221 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
34
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chemical and Clinical Development of Darinaparsin, a Novel Organic Arsenic Derivative
Anti-Cancer Agents in Medicinal Chemistry The Role of miRNAs in Plasma Cell Dyscrasias
MicroRNA Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
Current Cardiology Reviews Measles Virus as An Oncolytic Vector Platform
Current Gene Therapy Regulation of EMT by Notch Signaling Pathway in Tumor Progression
Current Cancer Drug Targets Skeletal Survey in Multiple Myeloma: Role of Imaging
Current Medical Imaging Subungueal Haemorrhages Following Docetaxel (Taxotere) Treatment
Current Drug Safety Structural Basis and Therapeutic Implication of the Interaction of CCN Proteins with Glycoconjugates
Current Pharmaceutical Design In Vitro Models of Human T Cell Development: Dishing Out Progenitor T Cells
Current Immunology Reviews (Discontinued) Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions
Current Medicinal Chemistry mTOR Inhibitors in Tuberous Sclerosis Complex
Current Neuropharmacology Immune Check Point Inhibitors Combination in Melanoma: Worth the Toxicity?
Reviews on Recent Clinical Trials Nampt/Visfatin/PBEF: A Functionally Multi-faceted Protein with a Pivotal Role in Malignant Tumors
Current Pharmaceutical Design Himalayan Plants as a Source of Anti-Cancer Agents: A Review
The Natural Products Journal Therapeutic Drug Monitoring of Busulfan in Transplantation
Current Pharmaceutical Design NK Cell Receptors and Their Interactions with MHC
Current Pharmaceutical Design The JAK-STAT Pathway: A Therapeutic Target in Hematological Malignancies
Current Cancer Drug Targets MicroRNAs and Cancer: Towards a Personalized Medicine
Current Molecular Medicine Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets Immune Therapy in Pancreatic Cancer: Now and the Future?
Reviews on Recent Clinical Trials